To further confirm that DRAK1 protein expression is associated with paclitaxel resistance in cervical cancer cells, we examined the viability of DRAK1-knockdown HeLa and CaSki cell lines after PTX treatment. This evidence concerns the gene STK17A and cervical cancer.